5
|
Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, Douek DC, Silvestri G, Müller-Trutwin M, Vasile-Pandrea I, Apetrei C, Hirsch V, Lifson J, Brenchley JM, Estes JD. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010; 84:7886-91. [PMID: 20484518 PMCID: PMC2897601 DOI: 10.1128/jvi.02612-09] [Citation(s) in RCA: 181] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2009] [Accepted: 05/07/2010] [Indexed: 02/06/2023] Open
Abstract
The mechanisms underlying the AIDS resistance of natural hosts for simian immunodeficiency virus (SIV) remain unknown. Recently, it was proposed that natural SIV hosts avoid disease because their plasmacytoid dendritic cells (pDCs) are intrinsically unable to produce alpha interferon (IFN-alpha) in response to SIV RNA stimulation. However, here we show that (i) acute SIV infections of natural hosts are associated with a rapid and robust type I IFN response in vivo, (ii) pDCs are the principal in vivo producers of IFN-alpha/beta at peak acute infection in lymphatic tissues, and (iii) natural SIV hosts downregulate these responses in early chronic infection. In contrast, persistently high type I IFN responses are observed during pathogenic SIV infection of rhesus macaques.
Collapse
Affiliation(s)
- Levelle D. Harris
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Brian Tabb
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Donald L. Sodora
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Mirko Paiardini
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Nichole R. Klatt
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Daniel C. Douek
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Guido Silvestri
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Michaela Müller-Trutwin
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Ivona Vasile-Pandrea
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Cristian Apetrei
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Vanessa Hirsch
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Jeffrey Lifson
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Jason M. Brenchley
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| | - Jacob D. Estes
- Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, Laboratory Animal Science Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, Seattle BioMed, Seattle, Washington, Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, Institut Pasteur, Régulation des Infections Rétrovirales, Paris, France, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland
| |
Collapse
|